HOME
• is remeron evil
• remeron plus cymbalta
• remeron and liver
• remeron substitute

remeron copyright pagesjaunes

Screening Patients for Bipolar Disorder A major depressive episode may be the initial presentation of bipolar disorder. Take the regular tablet form of Remeron with water. PRINCIPAL DISPLAY PANEL - 15 mg Carton NDC 0052-0106-30 30 Tablets ONCE-A-DAY RemeronSolTab® (mirtazapine) Orally Disintegrating Tablets Rx only 15 mg Organon Manufactured for Organon USA Inc., Roseland, NJ 07068 by CIMA Labs Inc., Eden Prairie, MN 55344 PRINCIPAL DISPLAY PANEL - 30 mg Carton NDC 0052-0108-30 30 Tablets ONCE-A-DAY RemeronSolTab® (mirtazapine) Orally Disintegrating Tablets Rx only 30 mg Organon Manufactured for Organon USA Inc., Roseland, NJ 07068 by remeron copyright pagesjaunes Labs Inc., Eden Prairie, MN 55344 PRINCIPAL DISPLAY PANEL - 45 mg Carton NDC 0052-0110-30 30 Tablets ONCE-A-DAY RemeronSolTab® (mirtazapine) Orally Disintegrating Tablets Rx only 45 mg Organon Manufactured for Organon USA Inc., Roseland, NJ 07068 by CIMA Labs Inc., Eden Prairie, MN 55344 RemeronSOLTAB  mirtazapine  tablet, orally disintegrating Product Information Product Type HUMAN PRESCRIPTION DRUG NDC Product Code (Source) 0052-0106 Route of Administration ORAL DEA Schedule      Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength MIRTAZAPINE (MIRTAZAPINE) MIRTAZAPINE 15 mg Inactive Ingredients Ingredient Name Strength ASPARTAME   CITRIC ACID MONOHYDRATE   CROSPOVIDONE   HYPROMELLOSE   MAGNESIUM STEARATE   MANNITOL   remeron copyright pagesjaunes MICROCRYSTALLINE   POVIDONE   SODIUM BICARBONATE   SUCROSE   Product Characteristics Color WHITE Score no score Shape ROUND remeron copyright pagesjaunes 16mm Flavor ORANGE Imprint Code T1Z Contains      Packaging # NDC Package Description Multilevel Packaging 1 0052-0106-30 5 BLISTER PACK In 1 BOX contains a BLISTER PACK 1 6 TABLET In 1 BLISTER PACK This package is contained within the BOX (0052-0106-30) 2 0052-0106-93 5 BLISTER PACK In 1 BOX contains a BLISTER PACK 2 6 TABLET In 1 BLISTER PACK This package is contained within the BOX (0052-0106-93) Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date NDA NDA021208 05/14/2010 RemeronSOLTAB  mirtazapine  tablet, orally disintegrating Product Information Product Type HUMAN PRESCRIPTION DRUG NDC Product Code (Source) 0052-0108 Route of Administration ORAL DEA Schedule      Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength MIRTAZAPINE (MIRTAZAPINE) MIRTAZAPINE 30 mg Inactive Ingredients Ingredient Name Strength ASPARTAME   CITRIC ACID MONOHYDRATE   CROSPOVIDONE   HYPROMELLOSE   MAGNESIUM STEARATE   remeron copyright pagesjaunes   CELLULOSE, MICROCRYSTALLINE   POVIDONE   SODIUM BICARBONATE   SUCROSE   Product Characteristics Color WHITE Score no score Shape ROUND Size 13mm Flavor ORANGE Imprint Code T2Z Contains      Packaging # NDC Package Description Multilevel Packaging 1 0052-0108-30 5 BLISTER PACK In 1 BOX contains a BLISTER PACK 1 6 TABLET In 1 BLISTER PACK This package is contained within the BOX (0052-0108-30) 2 0052-0108-93 5 BLISTER PACK In 1 BOX contains a BLISTER PACK 2 6 TABLET In 1 BLISTER PACK remeron copyright pagesjaunes package is contained within the BOX (0052-0108-93) Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date NDA NDA021208 05/14/2010 RemeronSOLTAB  mirtazapine  tablet, orally disintegrating Product Information Product Type HUMAN PRESCRIPTION DRUG NDC Product Code (Source) 0052-0110 remeron copyright pagesjaunes of Administration ORAL DEA Schedule      Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength MIRTAZAPINE (MIRTAZAPINE) MIRTAZAPINE 45 mg Inactive Ingredients Ingredient Name Strength ASPARTAME   CITRIC ACID MONOHYDRATE   CROSPOVIDONE   HYPROMELLOSE   MAGNESIUM STEARATE   MANNITOL   CELLULOSE, MICROCRYSTALLINE   POVIDONE   SODIUM BICARBONATE   SUCROSE   Product Characteristics Color WHITE Score no score Shape ROUND Size 10mm Flavor remeron copyright pagesjaunes Imprint Code T4Z Contains      Packaging # NDC Package Description Multilevel Packaging 1 0052-0110-30 5 BLISTER PACK In 1 BOX contains a BLISTER PACK 1 6 TABLET In 1 BLISTER PACK This package is contained within the BOX (0052-0110-30) Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date NDA NDA021208 05/14/2010 Labeler - Organon Pharmaceuticals USA (002152858) Establishment Name Address ID/FEI Operations NV ORGANON 402157499 MANUFACTURE Establishment Name Address ID/FEI Operations CIMA LABS 173625823 MANUFACTURE Revised: 06/2010Organon Pharmaceuticals USA Remeron Generic Name: Mirtazapine (mihr-TAZZ-uh-peen) Brand Name: Remeron Antidepressants may increase the risk of suicidal thoughts or actions in children, teenagers, and young adults.

Go To...

• remeron thrombocytopenia
• positive comments on remeron
• how to taper off remeron
• overdosage remeron
• remeron antihistamine

remeron copyright pagesjaunes

Use in Patients with Concomitant Illness Clinical experience with RemeronSolTab in remeron copyright pagesjaunes with concomitant systemic illness is limited. Additionally, the progression of major depression is associated with a worsening of symptoms and/or the emergence of suicidal thinking or remeron copyright pagesjaunes in both adults and children, whether or not they are taking antidepressants. The structural formula is the following and it is the racemic mixture: Mirtazapine is a white to creamy white crystalline powder which is slightly soluble in water. It affects chemicals in the brain that may become unbalanced and cause depression. remeron copyright pagesjaunes does remeron copyright pagesjaunes contain all information about Remeron. The efficacy of Remeron in maintaining a response in patients with major depressive disorder for up to 40 weeks following 8 to 12 weeks of initial open-label treatment was demonstrated in a placebo-controlled trial. Tell your doctor if you regularly use any of these medicines Many drugs can interact with mirtazapine. Mirtazapine clearance is decreased in patients with moderate renal impairment, and also in patients with hepatic impairment. Patients should be monitored for these and other symptoms when discontinuing treatment or during dosage reduction. Remember, keep this remeron copyright pagesjaunes all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed. Skip the missed dose if it is almost time for your next scheduled dose. Do not push a tablet through the foil or you may break the tablet. Using remeron copyright pagesjaunes hands, remove the tablet and place it in your mouth. Agranulocytosis Patients who are to receive RemeronSolTab should be warned about the risk of developing agranulocytosis. Follow your doctor's instructions. It remeron copyright pagesjaunes thought to increase the activity of norepinephrine and serotonin which help elevate mood. Swallow several times as the tablet dissolves. Gastrointestinal Gastrointestinal side effects including dry mouth (25%), increased appetite (17%), and constipation (13%) have been reported. Do not stop using mirtazapine suddenly, or you could have unpleasant withdrawal symptoms.